FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4849511000001103: Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    21382901000001118 Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    52663601000001119 Doxorubicin (liposomal) 50mg/25ml solution for infusion vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial Is a Virtual medicinal product pack false Inferred relationship Existential restriction modifier
    Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial Is pack of Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial false Inferred relationship Existential restriction modifier
    Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial Has active ingredient Doxorubicin hydrochloride false Inferred relationship Existential restriction modifier
    Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial Has active ingredient Doxorubicin false Inferred relationship Existential restriction modifier
    Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
    Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial Has VMP Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial false Inferred relationship Existential restriction modifier
    Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial Has specific active ingredient Doxorubicin hydrochloride false Inferred relationship Existential restriction modifier
    Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial Has dispensed dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) 1 vial Is a False Doxorubicin (liposomal) 50mg/25ml solution for injection vials 1 vial Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start